title: Burden of Alzheimer's disease and association with negative health outcomes.
abstract: OBJECTIVE
  To examine the association of Alzheimer's disease (AD) with common chronic conditions, acute care events, and risk of hospitalization.
  
  
  METHODS
  Retrospective matched cohort analysis.
  
  
  METHODS
  Community-dwelling subjects with a diagnosis of and/or medication for AD were matched to subjects without AD based on age, sex, and geographic region. Administrative claims from commercially insured health plans for medical and pharmacy services provided from January 1, 2000, to March 31, 2006 (inclusive) were analyzed. The Deyo Charlson Index (DCI) was used to assess the number of chronic conditions. The outcomes of interest were risk of fractures and hospitalization.
  
  
  RESULTS
  Among 5396 persons with AD and a matched cohort of 5396 persons without the condition, subjects with AD were more likely to have a diagnosis for any of the DCI components, had a higher rate of fractures (17.7% vs 7.9%, P <.00) and other urgent medical events (eg, pneumonia 14.0% vs 6.3%, P <.00), and were more likely to be hospitalized (odds ratio = 1.7; 95% confidence interval = 1.5, 1.9). There were significant differences in the medication use between the 2 groups, with the use of psychotics/tranquilizers 9-fold higher among persons with AD.
  
  
  CONCLUSIONS
  Persons with AD have higher odds of experiencing a fracture, being hospitalized, and requiring other acute care medical services than those without AD. The disease also is associated with a higher prevalence of common chronic conditions.
authors: College of Pharmacy, University of Arizona, Tucson, AZ 85721-0202, USA. malone@pharmacy.arizona.edu
authors: Daniel C
authors: DC
authors: Malone
authors: Trent P
authors: TP
authors: McLaughlin
authors: Peter M
authors: PM
authors: Wahl
authors: Christopher
authors: C
authors: Leibman
authors: H Michael
authors: HM
authors: Arrighi
authors: Mark J
authors: MJ
authors: Cziraky
authors: Lisa M
authors: LM
authors: Mucha
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000191:economics / Q000453:epidemiology*; D016022:Case-Control Studies; D002908:Chronic Disease / Q000453:epidemiology*; D015897:Comorbidity; D004358:Drug Therapy / Q000706:statistics & numerical data*; D005260:Female; D050723:Fractures, Bone / Q000453:epidemiology*; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007345:Insurance Claim Review; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012189:Retrospective Studies; D018434:Sickness Impact Profile; D014481:United States / Q000453:epidemiology
chemical_list: D011619:Psychotropic Drugs